Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1913 (LINC01913) is a non-protein-coding intergenic transcript, part of the long non-coding RNA family, expressed from chromosome 2p21. Recent clinical research identifies LINC01913 as a novel lncRNA with oncogenic properties, correlating its overexpression in gastric cancer tumors to lymph node metastasis, deeper tumor invasion, and poorer overall survival in affected patients. Functional evidence links LINC01913's regulatory roles to the PI3K-AKT and EMT pathways, which are critical in cancer cell proliferation and metastasis. Although LINC01913 is not a traditional therapeutic target, research highlights its potential value as a clinical biomarker for diagnosis and prognosis in gastro-intestinal malignancies, subject to ongoing validation in multicenter studies.
Not applicable; current data do not indicate a direct mechanism for drug action against LINC01913, though its regulation may intersect PI3K-AKT and EMT pathways, suggesting possible indirect modulation as understanding evolves.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1913 (LINC01913).